SPC Logo

Fosamax

Last Updated on eMC 06-May-2015 View document  | Merck Sharp & Dohme Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06-May-2015 and displayed until Current

Reasons for adding or updating:

  • Improved presentation of PIL

Updated on 12-Dec-2014 and displayed until 06-May-2015

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Updated on 12-Nov-2012 and displayed until 12-Dec-2014

Reasons for adding or updating:

  • Change to side-effects

Updated on 22-Dec-2011 and displayed until 12-Nov-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to drug interactions

Updated on 11-Nov-2011 and displayed until 22-Dec-2011

Reasons for adding or updating:

  • Change to side-effects

Updated on 04-Apr-2011 and displayed until 11-Nov-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects

Updated on 30-Mar-2010 and displayed until 04-Apr-2011

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to dosage and administration

Updated on 08-Aug-2008 and displayed until 30-Mar-2010

Reasons for adding or updating:

  • Change to side-effects
  • Change due to user-testing of patient information

Updated on 05-Mar-2007 and displayed until 08-Aug-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 23-Jan-2006 and displayed until 05-Mar-2007

Reasons for adding or updating:

  • Change to side-effects

Updated on 06-May-2004 and displayed until 23-Jan-2006

Reasons for adding or updating:

  • Change to side-effects
  • Change to warnings or special precautions for use

Updated on 21-Dec-2001 and displayed until 06-May-2004

Reasons for adding or updating:

  • Update to PIL

Updated on 18-Jul-2001 and displayed until 21-Dec-2001

Reasons for adding or updating:

  • Update to PIL

Updated on 17-Aug-2000 and displayed until 18-Jul-2001

Reasons for adding or updating:

  • No reasons supplied

Company contact details

Merck Sharp & Dohme Limited

Company image
Address

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU

Fax

+44 (0)1992 479 292

Stock Availability

Call MSD customer services on 01992 452094

Telephone

+44 (0)1992 467 272

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

alendronate sodium trihydrate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue